Loading...
UK Trademark — IPO
UK00914374136
Application UK00914374136 · Removed
Quick Facts
| Application Number | UK00914374136 |
| Status | Removed |
| Owner | Agilis Biotherapeutics, LLC |
| Filed | 2015-07-17 |
| Registered | 2015-11-12 |
| Renewal Due | 2025-07-17 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Is this trademark active?
UK00914374136 has a current status of Removed.
Goods & Services
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Class 5 — Pharmaceuticals
Pharmaceutical preparations; therapeutic pharmaceuticals for the treatment of Friedreich's ataxia and other life-threatening and rare diseases.
Class 35 — Advertising & Business
Business advisory services regarding the commercialization of products in the field of biotechnology.
Class 42 — Scientific & IT Services
Biotechnology research and development; Development of new technology for others in the field of biotechnology.
Device Elements (Vienna Classification)
This figurative mark is indexed under the following Vienna categories by the UK IPO:
- 02.01.95 — Human beings
Timeline
- Filed: 2015-07-17
- Registered: 2015-11-12
- Renewal due: 2025-07-17
About This Trademark
This device mark (application number UK00914374136) is a removed trademark on the UK IPO register, filed by Agilis Biotherapeutics, LLC on 17 July 2015, with registration granted on 12 November 2015. It is due to expire on 17 July 2025.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 42 (scientific, IT & design services).
The trademark is represented by Kilburn & Strode LLP.
Frequently Asked Questions
Is UK trademark UK00914374136 currently a registered trademark?
No — the UK IPO records the status of UK trademark UK00914374136 as removed.
Which Nice classes is UK trademark UK00914374136 registered under?
UK trademark UK00914374136 is recorded in Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical preparations; therapeutic pharmaceuticals for the treatment of Friedreich's ataxia and other life-threatening and rare diseases. | Class 35: Business advisory services regarding the commercialization of products in the field of biotechnology. | Class 42: Biotechnology research and development…
When was UK trademark UK00914374136 filed?
UK trademark UK00914374136 was filed at the UK IPO on 17 July 2015 and registered on 12 November 2015.
When does UK trademark UK00914374136 need to be renewed?
UK trademark UK00914374136 is currently recorded as valid until 17 July 2025, at which point it will need to be renewed with the UK IPO to remain in force.
Who is the attorney of record for UK trademark UK00914374136?
Kilburn & Strode LLP is listed as the attorney / representative of record for UK trademark UK00914374136 on the UK IPO register.
Attorney of Record
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Data Source
United Kingdom (Intellectual Property Office)
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.